CIK: 1688327 - Address: C/O Third Rock Ventures, LLC, 201 Brookline Ave, Suite 1401, Boston, MA 02215
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/17/24 16:48
9/13/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-71010.530-67016,859D
9/9/24 19:19
9/5/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-86711.560-75016,926D
9/4/24 20:42
8/30/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-2,03011.600-175-117,001D
8/29/24 16:40
8/27/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-28911.550-25017,176D
8/20/24 17:59
8/16/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS.m-2,8359.950-285-217,201D
8/1/24 17:51
7/30/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS.m-2,3169.860-235-117,486D
7/30/24 16:15
7/26/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-4929.840-50017,721D
7/26/24 16:15
7/24/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS.m-2,9569.830-301-217,771D
7/24/24 16:15
7/22/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS.m-3,7939.780-388-218,072D
7/22/24 16:15
7/18/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-1,8789.810-191-118,460D
7/18/24 16:15
7/17/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-5,3869.790-550-318,651D
2/21/24 17:52
2/20/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-1,95012.000-163-119,201D
2/9/23 16:30
2/7/23
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS.m-3,0560.82590-3,700-553,058D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact